References
- Hagell P, Odin P, Vinge E. 1998. Pregnancy in Parkinson’s disease: a review of the literature and a case report. Movement Disorders 13:34–38.
- Kranick SM, Mowry EM, Colcher A, Horn S, Golbe LI. 2010. Movement disorders and pregnancy: a review of the literature. Movement Disorders 25:665–671.
- Lamichhane D, Narayanan NS, Gonzalez-Alegre P. 2014. Two cases of pregnancy in Parkinson’s disease. Parkinsonism & Related Disorders 20:239–240.
- Lindh J. 2007. Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine. Movement Disorders 22:1515.
- Najib J. 2001. Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of parkinson’s disease. Clinical Therapeutics 23:802–832.
- Robottom BJ, Mullins RJ, Shulman LM. 2008. Pregnancy in Parkinson’s disease: case report and discussion. Expert Review Neurotherapy 8:1799–1805.
- Schrag A, Schott JM. 2006. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurology 5:355–363.
- Schrag A. 2005. Entacapone in the treatment of Parkinson’s disease. Lancet Neurology 4:366–370.
- Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, et al. 2010. Progression of Parkinson’s disease as evaluated by Hoehn and Yahr stage transition times. Movement Disorders 25:710–716.